Default

Shanghai LIDE Biotech Co., Ltd.

No Reviews Yet
No Completed Orders
Shanghai, Shanghai, CN

About Shanghai LIDE Biotech Co., Ltd.

Lab for Innovated Diagnosis and Experimental Therapeutics (LIDE) is a company for translational medicine. Founded in 2011 by overseas returnees Drs. Danyi Wen, Yizhun Zhu and few others, LIDE specializes in Oncology Translational Research and Immuno-oncology. With years of experience, LIDE has established a... Show more »

Lab for Innovated Diagnosis and Experimental Therapeutics (LIDE) is a company for translational medicine. Founded in 2011 by overseas returnees Drs. Danyi Wen, Yizhun Zhu and few others, LIDE specializes in Oncology Translational Research and Immuno-oncology. With years of experience, LIDE has established a unique collection of more than five hundred patient derived xenograft (PDX) models, cultured more than 30 PDX matching primary tumor cell lines. In addition to the PDX model, LIDE is investigating into PDX-Hu model and mouse tumor isograft (MTI) model.

LIDE adopts the high international standard in daily operation. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class equipments. Company brings together first-class research and management teams, with solid scientific background and project management experience.

LIDE focuses on the frontier of international translational medical research, and vigorously promotes the development and application of translational medical research in China.

Show less

Our Services (21)


ic

Immuno-oncology Assays

Price on request

LIDE IO CRO service can provide in vitro functional evaluation on certain immune checkpoints related targets.

LIDE IO CRO service can provide in vitro functional evaluation on certain immune checkpoints related targets.

Show less

ic

Cell Line Derived Xenograft (CDX) Models

Cell Line Derived Xenograft Models
Price on request
Request a quote for more information about this service.

ic

Hepatoma Xenograft

Price on request
Request a quote for more information about this service.

ic

Esophageal Xenograft

Price on request
Request a quote for more information about this service.

ic

Patient-Derived Xenograft (PDX)

Price on request

LIDE has established 600 + PDX models, including pancreatic , gastric, lung, liver, colon, CRC, ovarian, breast, esophageal, etc. We also evaluate drug efficacy on T790M model sensitive to AZD9291; and the model acquired AZD9291 drug resistance, and ALK model acquired drug resistance.

LIDE has established 600 + PDX models, including pancreatic , gastric, lung, liver, colon, CRC, ovarian, breast, esophageal, etc. We also evaluate drug efficacy on T790M model sensitive to AZD9291; and the model acquired AZD9291 drug resistance, and ALK model acquired drug resistance.

Show less

ic

Animal Models and Studies

Price on request
Request a quote for more information about this service.

ic

Animal Models of Disease

Price on request
Request a quote for more information about this service.

ic

Xenograft Models

Price on request
Request a quote for more information about this service.

ic

Immunostaining

Price on request

Immunostaining Services

Immunostaining Services

Show less

ic

Protein Expression Visualization

Price on request

Protein Expression Visualization Services

Protein Expression Visualization Services

Show less

ic

Protein Services

Price on request

Protein Services

Protein Services

Show less

ic

Biochemistry & Molecular Biology

Price on request

Biochemistry & Molecular Biology Services

Biochemistry & Molecular Biology Services

Show less

ic

Biology

Price on request

Biology Services

Biology Services

Show less

ic

Immunohistochemistry (IHC)

Price on request

LIDE Path/BM team has developed methods for quick evaluation of the histopathology of the organs after drug treatment. Based on surgical separation and collection of organ tissues, timely fixation and embedding for FFPE block, we provide service for sectioning, H&E staining and microscopic evaluation of the drug related pathologic... Show more »

LIDE Path/BM team has developed methods for quick evaluation of the histopathology of the organs after drug treatment. Based on surgical separation and collection of organ tissues, timely fixation and embedding for FFPE block, we provide service for sectioning, H&E staining and microscopic evaluation of the drug related pathologic changes to support non-GLP toxicity studies for drug development.

IHC profiling and biomarker confirmation

LIDE has accumulated tremendous experience of IHC studies over the years of CRO studies, particularly worked on many biomarkers from oncology drug target related initiatives

Show less

ic

Immunoassays

Price on request

Immunoassays Services

Immunoassays Services

Show less

ic

Bioanalytical Assays

Price on request

Bioanalytical Assays Services

Bioanalytical Assays Services

Show less

ic

Bioanalysis

Price on request

Bioanalysis Services

Bioanalysis Services

Show less

ic

Pharmacology

Price on request

Pharmacology Services

Pharmacology Services

Show less

ic

Pharmacology & Toxicology

Price on request

Pharmacology & Toxicology Services

Pharmacology & Toxicology Services

Show less

ic

Drug Discovery & Development

Price on request

Drug Discovery & Development Services

Drug Discovery & Development Services

Show less

ic

Oncology Animal Models

Price on request
Request a quote for more information about this service.

Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
WH

Wenqiang Huang

BD Manager
ML

Meixiang Li

Director of Corp BD
DW

Danyi Wen

Founder & CEO
JZ

Jun Zhang

Executive Director of New Assay Development

Shanghai LIDE Biotech Co., Ltd. has not received any reviews.

Shanghai LIDE Biotech Co., Ltd. has not received any endorsements.